tiprankstipranks
Trending News
More News >
Immunovant (IMVT)
NASDAQ:IMVT
US Market
Advertisement

Immunovant (IMVT) Technical Analysis

Compare
842 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
6Neutral
3Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Immunovant’s (IMVT) Moving Averages Convergence Divergence (MACD) indicator is 0.62, suggesting Immunovant is a Sell.
Immunovant’s (IMVT) 20-Day exponential moving average is 17.44, while Immunovant’s (IMVT) share price is $18.32, making it a Buy.
Immunovant’s (IMVT) 50-Day exponential moving average is 16.74, while Immunovant’s (IMVT) share price is $18.32, making it a Buy.

Immunovant (IMVT) Pivot Points

Jul 26, 2025, 04:25 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
17.11
17.56
17.98
18.43
18.85
19.30
19.72
Fibonacci
17.56
17.90
18.10
18.43
18.77
18.97
19.30
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Immunovant (IMVT) Moving Averages

Jul 26, 2025, 04:25 AM
Period
Simple
Exponential
MA5
18.05Buy
18.14Buy
MA10
18.06Buy
17.91Buy
MA20
17.35Buy
17.44Buy
MA50
16.08Buy
16.74Buy
MA100
16.36Buy
17.50Buy
MA200
21.10Sell
21.30Sell
Immunovant’s (IMVT) 10-Day exponential moving average is 17.91, while Immunovant’s (IMVT) share price is $18.32, making it a Buy.
Immunovant’s (IMVT) 100-Day exponential moving average is 17.50, while Immunovant’s (IMVT) share price is $18.32, making it a Buy.
Immunovant’s (IMVT) stock price is $18.32 and Immunovant’s (IMVT) 50-day simple moving average is 16.08, creating a Buy signal.
Immunovant’s (IMVT) stock price is $18.32 and Immunovant’s (IMVT) 100-day simple moving average is 16.36, creating a Buy signal.
Immunovant’s (IMVT) stock price is $18.32 and Immunovant’s (IMVT) 200-day simple moving average is 21.10, creating a Sell signal.

Immunovant (IMVT) Technical Indicators

Jul 26, 2025, 04:25 AM
Name
Value
Implied Action
RSI (14)
61.80
Neutral
STOCH (9,6)
56.91
Neutral
STOCHRSI (14)
71.04
Neutral
MACD (12,26)
0.62
Sell
ADX (14)
31.17
Neutral
Williams %R
-26.40
Buy
CCI (14)
88.97
Neutral
ATR (14)
0.77
-
Ultimate Oscillator
48.54
Neutral
ROC
8.08
Buy
Immunovant’s (IMVT) Relative Strength Index (RSI) is 61.80, creating a Neutral signal.
Immunovant’s (IMVT) Trend Strength Indicator (ADX) is 31.17, creating a Neutral signal.
Immunovant’s (IMVT) Commodity Channel Index (CCI) is 88.97, creating a Neutral signal.
Immunovant’s (IMVT) Price Rate of Change (ROC) is 8.08, creating a Buy signal.

FAQ

Is IMVT a Buy, Hold, or Sell?
Based on IMVT’s technical indicators, IMVT is a Buy.
    What is IMVT’s RSI (14)?
    IMVT’s RSI (14) is 61.80, which suggests IMVT is a Neutral.
      What is IMVT’s MACD?
      IMVT’s MACD is 0.62, which suggests IMVT is a Sell.
        What is IMVT’s 5-day moving average?
        IMVT’s 5-day moving average is 18.05, which suggests IMVT is a Buy.
          What is IMVT’s 20-day moving average?
          IMVT 20-day moving average is 17.35, which suggests IMVT is a Buy.
            What is IMVT’s 50-day moving average?
            IMVT’s 50-day moving average is 16.08, which suggests IMVT is a Buy.
              What is IMVT’s 200-day moving average?
              IMVT’s 200-day moving average is 21.10, which suggests IMVT is a Sell.
                What is IMVT’s Williams % R (14)?
                IMVT’s Williams % R (14) is -26.40, which suggests IMVT is a Buy.
                  What is IMVT’s CCI (14)?
                  IMVT’s CCI (14) is 88.97, which suggests IMVT is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis